Takeda Pharma paid $10M to Affymax after FDA approval of an application for peginesatide
PALO ALTO, CA — Earlier on Wednesday, Affymax Inc. announced that it received a milestone payment of a whopping $10
Read more
Clinical Research Society
International Society for Clinical Research and Translational Medicine